Mammalian receptors for glucagon-like-peptide-1 (GLP-1), corresponding DNA and recombinant expression systems, and screening assays for GLP-1 agonists and enhancers
US5670360A · kind A · utility
54Cited by
0References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 24, 1993 |
| Grant date | Sep 23, 1997 |
| Priority date | — |
| Expiry date | Nov 24, 2013 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/72
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to a recombinant glucagon like peptide-1 (GLP-1), to a DNA construct which comprises a DNA sequence encoding a GLP-1 receptor, to methods of screening for agonists of GLP-1 activity, and to the use of the GLP-1 receptor for screening for agonists of GLP-1 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.